✦ LIBER ✦

Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial

✍ Scribed by Orkin, C; DeJesus, E; Khanlou, H; Stoehr, A; Supparatpinyo, K; Lathouwers, E; Lefebvre, E; Opsomer, M; Van de Casteele, T; Tomaka, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, Efficacy, and Safety o

✍ Boffito, Marta; Miralles, Diego; Hill, Andrew 📂 Article 📅 2008 🏛 Thomas Land Publishers, Inc. 🌐 English ⚖ 194 KB

Efficacy and safety of darunavir-ritonav

✍ José Valdez Madruga; Daniel Berger; Marilyn McMurchie; Fredy Suter; Denes Banheg 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 193 KB

Once-daily atazanavir/ritonavir versus t

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Long-term (96-week) follow-up of antiret

✍ J Ghosn; P Flandre; I Cohen-Codar; P-M Girard; M-L Chaix; F Raffi; P Dellamonica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/R

✍ A. Juarez-Garcia; G. Martinez-Rivera; B.M. Donato 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Efficacy and safety of darunavir-ritonav

✍ Bonaventura Clotet; Nicholas Bellos; Jean-Michel Molina; David Cooper; Jean-Chri 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 180 KB